131 related articles for article (PubMed ID: 12586590)
81. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma.
Fujiwaki R; Iida K; Nakayama K; Kanasaki H; Hata K; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2003 Apr; 89(1):77-83. PubMed ID: 12694657
[TBL] [Abstract][Full Text] [Related]
82. Prognostic significance of serum tumour markers in carcinoma of the cervix.
Ngan HY; Cheung AN; Lauder IJ; Wong LC; Ma HK
Eur J Gynaecol Oncol; 1996; 17(6):512-7. PubMed ID: 8971531
[TBL] [Abstract][Full Text] [Related]
83. Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer.
Nakamura K; Abarzua F; Hongo A; Kodama J; Nasu Y; Kumon H; Hiramatsu Y
Ann Oncol; 2009 Jan; 20(1):63-70. PubMed ID: 18689863
[TBL] [Abstract][Full Text] [Related]
84. Significance of erb-B2 immunoreactivity in cervical cancer.
Califano D; Losito S; Pisano C; Santelli G; Greggi S; Iodice F; DiVagno G; Silvestro G; Tambaro R; Formato R; Iaffaioli VR; Di Maio M; Pignata S
Front Biosci; 2006 Sep; 11():2071-6. PubMed ID: 16720293
[TBL] [Abstract][Full Text] [Related]
85. Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer.
Nishimura S; Tsuda H; Nomura H; Kataoka F; Chiyoda T; Tanaka H; Tanaka K; Susumu N; Aoki D
Eur J Gynaecol Oncol; 2011; 32(2):146-9. PubMed ID: 21614900
[TBL] [Abstract][Full Text] [Related]
86. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
Altavilla G; Castellan L; Wabersich J; Marchetti M; Onnis A
Eur J Gynaecol Oncol; 1996; 17(4):267-70. PubMed ID: 8856301
[TBL] [Abstract][Full Text] [Related]
87. Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma.
Lerma E; Romero M; Gallardo A; Pons C; Muñoz J; Fuentes J; Lloveras B; Catasus L; Prat J
Virchows Arch; 2008 Jan; 452(1):65-74. PubMed ID: 18000680
[TBL] [Abstract][Full Text] [Related]
88. Prognostic value of podoplanin expression in intratumoral stroma and neoplastic cells of uterine cervical carcinomas.
Carvalho FM; Zaganelli FL; Almeida BG; Goes JC; Baracat EC; Carvalho JP
Clinics (Sao Paulo); 2010; 65(12):1279-83. PubMed ID: 21340215
[TBL] [Abstract][Full Text] [Related]
89. Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome.
Kohlberger P; Edwards L; Hacker NF
Gynecol Oncol; 2003 Aug; 90(2):443-5. PubMed ID: 12893215
[TBL] [Abstract][Full Text] [Related]
90. [Hypoxia in cervical cancer: pathogenesis, characterization, and biological/clinical consequences].
Vaupel P; Höckel M
Zentralbl Gynakol; 2001 Apr; 123(4):192-7. PubMed ID: 11370526
[TBL] [Abstract][Full Text] [Related]
91. Prognostic value of c-Met expression in oral squamous cell carcinoma.
Freudlsperger C; Alexander D; Reinert S; Hoffmann J
Exp Ther Med; 2010 Jan; 1(1):69-72. PubMed ID: 23136595
[TBL] [Abstract][Full Text] [Related]
92. Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting.
Kim HJ
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630066
[TBL] [Abstract][Full Text] [Related]
93. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer.
Sudhesh Dev S; Zainal Abidin SA; Farghadani R; Othman I; Naidu R
Front Pharmacol; 2021; 12():772510. PubMed ID: 34867402
[TBL] [Abstract][Full Text] [Related]
94. Dependence receptors: new targets for cancer therapy.
Brisset M; Grandin M; Bernet A; Mehlen P; Hollande F
EMBO Mol Med; 2021 Nov; 13(11):e14495. PubMed ID: 34542930
[TBL] [Abstract][Full Text] [Related]
95. Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence.
Wang Q; Peng H; Qi X; Wu M; Zhao X
Signal Transduct Target Ther; 2020 Jul; 5(1):137. PubMed ID: 32728057
[TBL] [Abstract][Full Text] [Related]
96. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
Patel S; Alam A; Pant R; Chattopadhyay S
Front Immunol; 2019; 10():2872. PubMed ID: 31921137
[TBL] [Abstract][Full Text] [Related]
97. Verticillin A suppresses HGF-induced migration and invasion via repression of the c-Met/FAK/Src pathway in human gastric and cervical cancer cells.
Lu J; Li X; Tu K; Guan Y; Fung KP; Liu F
Onco Targets Ther; 2019; 12():5823-5833. PubMed ID: 31440058
[No Abstract] [Full Text] [Related]
98. Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.
Scott ML; Coleman DT; Kelly KC; Carroll JL; Woodby B; Songock WK; Cardelli JA; Bodily JM
Virology; 2018 Jun; 519():1-11. PubMed ID: 29609071
[TBL] [Abstract][Full Text] [Related]
99. MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met.
Guo Y; Tao M; Jiang M
Exp Ther Med; 2018 Mar; 15(3):2301-2306. PubMed ID: 29563976
[TBL] [Abstract][Full Text] [Related]
100. Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
Ueda A; Takasawa A; Akimoto T; Takasawa K; Aoyama T; Ino Y; Nojima M; Ono Y; Murata M; Osanai M; Hasegawa T; Saito T; Sawada N
PLoS One; 2017; 12(8):e0184123. PubMed ID: 28859123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
